The researchers further showed that inhibiting the recruitment of TAMs decreased pSTAT3 expression and IL-6 secretion within the TME, leading to delayed IBC tumor formation and reduced skin invasion and local recurrence. This evidence concerns the gene IL6 and inflammatory breast carcinoma.